AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chacon, O.
Right arrow Articles by Barletta, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chacon, O.
Right arrow Articles by Barletta, R. G.
Antimicrobial Agents and Chemotherapy, January 2002, p. 47-54, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.2.47-54.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Mycobacterium smegmatis D-Alanine Racemase Mutants Are Not Dependent on D-Alanine for Growth {dagger}

Ofelia Chacon,1,2 Zhengyu Feng,1 N. Beth Harris,1 Nancy E. Cáceres,1 L. Garry Adams,2 and Raúl G. Barletta1*

Department of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583-0905,1 Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A & M University, College Station, Texas 77843-44672

Received 29 May 2001/ Returned for modification 13 July 2001/ Accepted 25 September 2001

Mycobacterium smegmatis is a fast-growing nonpathogenic species particularly useful in studying basic cellular processes of relevance to pathogenic mycobacteria. This study focused on the D-alanine racemase gene (alrA), which is involved in the synthesis of D-alanine, a basic component of peptidoglycan that forms the backbone of the cell wall. M. smegmatis alrA null mutants were generated by homologous recombination using a kanamycin resistance marker for insertional inactivation. Mutants were selected on Middlebrook medium supplemented with 50 mM D-alanine and 20 µg of kanamycin per ml. These mutants were also able to grow in standard and minimal media without D-alanine, giving rise to colonies with a drier appearance and more-raised borders than the wild-type strain. The viability of the mutants and independence of D-alanine for growth indicate that inactivation of alrA does not impose an auxotrophic requirement for D-alanine, suggesting the existence of a new pathway of D-alanine biosynthesis in M. smegmatis. Biochemical analysis demonstrated the absence of any detectable D-alanine racemase activity in the mutant strains. In addition, the alrA mutants displayed hypersusceptibility to the antimycobacterial agent D-cycloserine. The MIC of D-cycloserine for the mutant strain was 2.56 µg/ml, 30-fold less than that for the wild-type strain. Furthermore, this hypersusceptibility was confirmed by the bactericidal action of D-cycloserine on broth cultures. The kinetic of killing for the mutant strain followed the same pattern as that for the wild-type strain, but at a 30-fold-lower drug concentration. This effect does not involve a change in the permeability of the cell wall by this drug and is consistent with the identification of D-alanine racemase as a target of D-cycloserine. This outcome is of importance for the design of novel antituberculosis drugs targeting peptidoglycan biosynthesis in mycobacteria.


* Corresponding author. Mailing address: Department of Veterinary and Biomedical Sciences, 211 VBS, Fair St. and East Campus Loop, University of Nebraska, Lincoln, NE 68583-0905. Phone: (402) 472-8543. Fax: (402) 472-9690. E-mail: rbarletta{at}unl.edu.

{dagger} Journal Series no. 13366, Agricultural Research Division, University of Nebraska—Lincoln.


Antimicrobial Agents and Chemotherapy, January 2002, p. 47-54, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.2.47-54.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.